These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 27567805

  • 1. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    Martire S, Fuso A, Mosca L, Forte E, Correani V, Fontana M, Scarpa S, Maras B, d'Erme M.
    J Alzheimers Dis; 2016 Aug 10; 54(1):307-24. PubMed ID: 27567805
    [Abstract] [Full Text] [Related]

  • 2. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
    Abeti R, Abramov AY, Duchen MR.
    Brain; 2011 Jun 10; 134(Pt 6):1658-72. PubMed ID: 21616968
    [Abstract] [Full Text] [Related]

  • 3. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
    Arias C, Montiel T, Quiroz-Báez R, Massieu L.
    Exp Neurol; 2002 Jul 10; 176(1):163-74. PubMed ID: 12093093
    [Abstract] [Full Text] [Related]

  • 4. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
    Pohland M, Pellowska M, Asseburg H, Hagl S, Reutzel M, Joppe A, Berressem D, Eckert SH, Wurglics M, Schubert-Zsilavecz M, Eckert GP.
    Alzheimers Res Ther; 2018 Feb 13; 10(1):18. PubMed ID: 29433569
    [Abstract] [Full Text] [Related]

  • 5. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X, Hu X, Yang Y, Takata T, Sakurai T.
    Exp Neurol; 2015 Sep 13; 271():145-54. PubMed ID: 26057947
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PARP-1 modulates amyloid beta peptide-induced neuronal damage.
    Martire S, Fuso A, Rotili D, Tempera I, Giordano C, De Zottis I, Muzi A, Vernole P, Graziani G, Lococo E, Faraldi M, Maras B, Scarpa S, Mosca L, d'Erme M.
    PLoS One; 2013 Sep 13; 8(9):e72169. PubMed ID: 24086258
    [Abstract] [Full Text] [Related]

  • 9. Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
    Yu Y, Fedele G, Celardo I, Loh SHY, Martins LM.
    Cell Death Dis; 2021 Jun 25; 12(7):651. PubMed ID: 34172715
    [Abstract] [Full Text] [Related]

  • 10. Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus.
    Adamczyk A, Jeśko H, Strosznajder RP.
    Folia Neuropathol; 2005 Jun 25; 43(3):139-42. PubMed ID: 16245207
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.
    Krainz T, Lamade AM, Du L, Maskrey TS, Calderon MJ, Watkins SC, Epperly MW, Greenberger JS, Bayır H, Wipf P, Clark RSB.
    ACS Chem Biol; 2018 Oct 19; 13(10):2868-2879. PubMed ID: 30184433
    [Abstract] [Full Text] [Related]

  • 12. Non A beta component of Alzheimer's disease amyloid and amyloid beta peptides evoked poly(ADP-ribose) polymerase-dependent release of apoptosis-inducing factor from rat brain mitochondria.
    Adamczyk A, Czapski GA, Jeśko H, Strosznajder RP.
    J Physiol Pharmacol; 2005 Mar 19; 56 Suppl 2():5-13. PubMed ID: 16077187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders.
    Czapski GA, Cieślik M, Wencel PL, Wójtowicz S, Strosznajder RP, Strosznajder JB.
    Biochim Biophys Acta Mol Cell Res; 2018 Feb 19; 1865(2):281-288. PubMed ID: 29128369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A cell model for the initial phase of sporadic Alzheimer's disease.
    Stockburger C, Gold VA, Pallas T, Kolesova N, Miano D, Leuner K, Müller WE.
    J Alzheimers Dis; 2014 Feb 19; 42(2):395-411. PubMed ID: 24898661
    [Abstract] [Full Text] [Related]

  • 18. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W, Alano CC, Garnier P, Swanson RA.
    J Neurosci Res; 2014 Feb 19; 79(1-2):216-23. PubMed ID: 15562437
    [Abstract] [Full Text] [Related]

  • 19. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H, Jankowska-Kulawy A, Höfling C, Ronowska A, Gul-Hinc S, Roßner S, Schliebs R, Pawelczyk T, Szutowicz A.
    J Alzheimers Dis; 2015 Feb 19; 48(4):1083-94. PubMed ID: 26402099
    [Abstract] [Full Text] [Related]

  • 20. Reduced levels of mitochondrial complex I subunit NDUFB8 and linked complex I + III oxidoreductase activity in the TgCRND8 mouse model of Alzheimer's disease.
    Francis BM, Yang J, Song BJ, Gupta S, Maj M, Bazinet RP, Robinson B, Mount HT.
    J Alzheimers Dis; 2014 Feb 19; 39(2):347-55. PubMed ID: 24217272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.